David E. Wheadon

Director, Vaxart.

Companies

Seaport Therapeutics, Inc.Board member Apr 30, 2026 to now¹
IndiviorBoard member Jan 7, 2026 to now²
Sotera Health CoBoard member May 28, 2021 to now³
VaxartBoard member Apr 23, 2021 to now⁴
Karuna TherapeuticsBoard member Dec 3, 2020 to Mar 18, 2024⁵
ChemoCentryx, Inc.Board member May 31, 2022 to Oct 24, 2022⁶
Assertio Holdings, Inc.Board member May 21, 2020 to Sep 29, 2020⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Vaxart VXRT86,150 shares⁸$39.6K at $0.46Jul 16, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 16, 2026Granted 39,400 shares of Vaxart⁸
Jun 13, 2025Granted 16,000 shares of Vaxart⁹
Jun 11, 2024Granted 16,000 shares of Vaxart¹⁰
Jun 26, 2023Granted 7,375 shares of Vaxart¹¹
Aug 4, 2022Granted 7,375 shares of Vaxart¹²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSeaport Therapeutics, Inc., Board member
2
SEC EDGARIndivior, Board member
3
SEC EDGARSotera Health Co, Board member
4
SEC EDGARVaxart, Board member
5
SEC EDGARKaruna Therapeutics, Board member
6
SEC EDGARChemoCentryx, Inc., Board member
7
SEC EDGARAssertio Holdings, Inc., Board member
8
SEC EDGARVaxart shares after the filing of Jul 16, 2026
9
SEC EDGARForm 4 filed Jun 16, 2025
10
SEC EDGARForm 4 filed Jun 12, 2024
11
SEC EDGARForm 4 filed Aug 1, 2023
12
SEC EDGARForm 4 filed Aug 8, 2022